FORTUNATO, GIULIANA
 Distribuzione geografica
Continente #
AS - Asia 6.843
NA - Nord America 6.811
EU - Europa 4.912
SA - Sud America 889
Continente sconosciuto - Info sul continente non disponibili 209
AF - Africa 202
OC - Oceania 9
Totale 19.875
Nazione #
US - Stati Uniti d'America 6.494
SG - Singapore 3.140
RU - Federazione Russa 2.105
CN - Cina 1.302
VN - Vietnam 1.198
IT - Italia 1.036
BR - Brasile 689
HK - Hong Kong 501
DE - Germania 327
FR - Francia 279
NL - Olanda 245
FI - Finlandia 191
CA - Canada 180
UA - Ucraina 178
GB - Regno Unito 145
BD - Bangladesh 128
IN - India 122
IE - Irlanda 118
JP - Giappone 92
AR - Argentina 85
MX - Messico 77
SE - Svezia 76
CI - Costa d'Avorio 74
ZA - Sudafrica 54
PL - Polonia 47
KR - Corea 43
IQ - Iraq 42
TH - Thailandia 37
PH - Filippine 34
EC - Ecuador 29
ES - Italia 26
CO - Colombia 25
AT - Austria 24
ID - Indonesia 24
PK - Pakistan 24
TR - Turchia 23
CZ - Repubblica Ceca 19
VE - Venezuela 19
JM - Giamaica 17
PY - Paraguay 16
KE - Kenya 14
LT - Lituania 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
IR - Iran 13
TW - Taiwan 13
NP - Nepal 12
MA - Marocco 11
UZ - Uzbekistan 11
MY - Malesia 9
UY - Uruguay 9
CR - Costa Rica 8
SA - Arabia Saudita 8
AL - Albania 7
EG - Egitto 7
TN - Tunisia 7
BE - Belgio 6
BG - Bulgaria 6
CL - Cile 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
JO - Giordania 6
LB - Libano 6
PE - Perù 6
AU - Australia 5
BY - Bielorussia 5
GR - Grecia 5
HN - Honduras 5
KZ - Kazakistan 5
LV - Lettonia 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BO - Bolivia 4
PT - Portogallo 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
IL - Israele 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SC - Seychelles 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
CV - Capo Verde 2
CY - Cipro 2
DM - Dominica 2
EU - Europa 2
GE - Georgia 2
Totale 19.628
Città #
Singapore 1.543
San Jose 1.088
Ashburn 553
Moscow 494
Chandler 489
Hong Kong 471
Beijing 397
Ho Chi Minh City 344
Hanoi 260
Santa Clara 258
Hefei 195
Los Angeles 191
Amsterdam 190
Council Bluffs 179
Dallas 166
Lauterbourg 166
Jacksonville 161
The Dalles 158
Naples 153
Millbury 132
Boston 130
Princeton 124
New York 121
Nanjing 99
Napoli 98
Buffalo 89
Boardman 83
Tokyo 82
São Paulo 74
Munich 71
Milan 57
Haiphong 54
Ottawa 54
Wilmington 53
Brooklyn 52
Da Nang 45
Redondo Beach 45
Phoenix 43
Helsinki 42
Orem 42
Frankfurt am Main 40
Nuremberg 40
Rome 39
Nanchang 38
Montreal 37
Toronto 36
Warsaw 36
Dong Ket 34
Des Moines 33
Seattle 33
Chennai 32
Mexico City 31
Denver 30
Chicago 29
Seoul 27
Johannesburg 26
Lawrence 26
Shenyang 25
Dublin 24
Houston 24
Stockholm 24
Washington 24
London 23
Atlanta 22
Turku 22
Baghdad 21
Hải Dương 20
Rio de Janeiro 20
Tianjin 20
Woodbridge 20
Hebei 19
Poplar 18
Marsala 17
Norwalk 17
Falls Church 16
Kronberg 16
San Francisco 16
Biên Hòa 15
Bologna 15
Shanghai 15
Bangkok 14
Curitiba 14
Falkenstein 14
Manchester 14
Mumbai 14
Nairobi 14
Redwood City 14
Brno 13
Augusta 12
Brasília 12
Guayaquil 12
Changsha 11
Charlotte 11
Ercolano 11
Ankara 10
Florence 10
Thái Nguyên 10
Vienna 10
Belo Horizonte 9
Campinas 9
Totale 10.304
Nome #
Biochimica del pancreas 212
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: correlation with plaque presence and features 187
Heterogeneity of malignant hyperthermia: a study in families from the south of Italy. 184
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. 180
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 177
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 170
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 167
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 166
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 161
Cardiac troponin T and amino-terminal pro-natriuretic peptide concentrations in fetuses in the second trimester and in healthy neonates. 160
A case of cerebrotendinous xanthomatosis in a woman with a normal cholesterolemia. 160
A paraoxonase gene polymorphism pon 1 (55) as an independent factor for increased carotid imt in women 158
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 155
Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss. 153
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis 152
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 151
Livelli sierici degli isoenzimi della LDH e della pseudoridina in leucemie e linfomi 151
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 149
A case of discordance between phenotype and genotype in malignant hyperthermia in the presence of the arg614cys mutation in the RYR1 gene 148
Expression of inflammation-related genes in human atherosclerotic plaques. 147
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 147
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 147
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 146
Identification and functional characterization of a new mutation leading to defective uptake of LDL-LDLR complex. 144
Genetic linkage analysis in Italian malignant hyperthermia families. 144
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 144
Prevalence and Long-term corse of macro-aspartate aminotransferase in children 143
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 142
A case of cerebrotendinous xantomatosis in a woman with a normal colesterolemia 142
Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia 142
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 141
Decreased paraoxonase - 2 expression in human carotids during the progression of atherosclerosis 140
A case of discordance between genotype and phenotype in a malignant hyperthermia family 139
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy 139
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 139
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 138
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio 137
Mutations in the RYR1 gene and their functional characterization in immortalized lymphocytes by detection of proton release rate. 136
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 136
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 135
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 135
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia 135
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 135
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 134
Age-related changes of cholestanol and lathosterol plasma concentrations: An explorative study 134
Identification of deletions in LDLR gene by Multiplex Ligation-Dependent Probe Amplification Analysis. 133
RAS and MTHFR gene polymorphisms in a healthy exercise-trained population:association with the MTHFR (TT) genotype and a lower hemoglobin level. 131
An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations. 130
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 130
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 129
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes 129
Identification of Single Nucleotide Polymorphisms associated to Familial Combined Hyperlipidemia. 128
Familial hypercholesterolemia: a flow chart for the molecular diagnosis. 127
Relazione tra polimorfismi del gene paraoxonasi ed ischemia miocardica indotta da stress in pazienti con sospetta malattia coronarica 127
Functional characterization of novel RYR1 mutations using a metabolic assay of B-lymphocytes. 127
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 126
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA) 126
Expression of inflammation-related genes in human atherosclerotic plaque. 126
Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests. 126
Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries. 126
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 125
Familial Combined Hyperlipidemia: identification of misdiagnosed patients by detection of LDLR mutations. 124
Metabolic overreaction in response to 4-chloro-m-cresol in immortalized B-lymphocytes from malignant hyperthermia susceptible individuals with a novel RYR1 mutation. 124
Serum Pseudouridine In the Diagnosis of Acute Leukemias and As A Novel Prognostic Indicator In Acute Lymphoblastic-leukemia 123
Novel mutations in the ryanodine receptor gene (RYR1) identified in malignant hyperthermia susceptible subjects. 123
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. 123
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis 122
A case of discordance between genotype and phenotype in a malignant hyperthermia family. 121
Targeting Nanostrategies for Imaging of Atherosclerosis 121
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 120
A multilayer perceptron neural network-based approach for the identification of responsiveness to interferon therapy in multiple sclerosis patients 120
Association between apolipoprotein E polymorphisms and metabolic syndrome in women. 120
Linkage analysis of the ryanodine receptor (RYR1) gene in Italian malignant hyperthermia families. 120
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 119
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 118
Correlation between low adenosine A2A receptor expression and hypercholesterolemia: A new component of the cardiovascular risk? 118
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 117
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 116
Identification of new polymorphisms in the CACNA1S gene. 116
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis 116
The CEINGE Biobank of biological samples: storage and management 116
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports 116
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia 116
A first comparative study on two cell colture techniques – stimulated T cells and continous lymphoblastoid cell lines – in the detection of LDL receptor residual activity versus molecular genetic analysys 115
Biochimica del muscolo cardiaco 115
The use of receiver operating characteristic (ROC) curves analysis in the evaluation of the diagnostic efficiency of serum pseudouridine as a tumor marker 115
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 115
EXPRESSION OF ADIPONECTIN RECEPTORS IN HUMAN CAROTID ATHEROSCLEROTIC PLAQUES Abstracts from the 12th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 6–8 March 2014 114
Malignant hyperthermia: from prevention to diagnosis 113
Identificazione e caratterizzazione funzionale di mutazioni nel gene LDLR in pazienti del sud Italia affetti da Ipercolesterolemia familiare. 113
Identification and functional characterization of the malignant hyperthermia mutation T1354S in the α1S subunit of the skeletal muscle voltage-gated calcium channel. 113
Sequence Analysis of the UCP1 Gene in a Severe ObesePopulation from Southern Italy. 113
Genetic heterogeneity of malignant hyperthermia in Italian families. 113
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family 112
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 111
Rare variants in PKHD1 associated with Caroli syndrome: Two case reports 110
ECHOCARDIOGRAFIC ANDECO-DOPPLER ABNORMALITIESIN RELATION TO LDL CHOLESTEROLIN FAMILIAL HYPERCHOLESTEROLEMIA 110
Malignant hyperthermia in Italian families. 110
Another lactate dehydrogenase-IgA complex in serum 109
Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis 109
Totale 13.367
Categoria #
all - tutte 66.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022838 0 0 2 12 17 7 6 42 95 63 243 351
2022/20231.189 160 61 36 91 168 134 4 118 166 181 56 14
2023/2024857 34 117 69 62 49 92 21 114 8 42 139 110
2024/20254.998 262 257 22 149 143 240 514 299 405 508 1.781 418
2025/20269.531 1.123 666 883 931 1.758 396 1.063 471 1.114 613 254 259
2026/2027827 292 369 166 0 0 0 0 0 0 0 0 0
Totale 19.875